ZEB1 was also found to have an inhibitory transcriptional function by binding to the promoter region of LIF to suppress its expression in glioma cancer stem cells,25 which inspired us to investigate the role of HIF1α and the ZEB1/LIF axis in hepatic I/R injury. The gene discussed is LIF; the disease is central nervous system cancer.